Do Analysts See Any Upside to ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) Shares?

During the past trading session, shares of ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) traded -2.604%. Covering analysts are predicting the stock to move to $13.050 within the next year. Depending on the analyst, target price projections may differ widely. This target price is a consensus number based on polled analysts by Thomson Reuters. 

Analysts and investors may use different metrics in order to calculate a price target projection. A very common metric used is the price to earnins ratio of a company. This calculation comes from dividing the current share price by the projected earnings per share. At the time of writing, ARIAD Pharmaceuticals, Inc. has a P/E Ratio of N/A. Investors may also examine a company’s PEG or price to earnings growth ratio. The PEG ratio represents the ratio of the price to earnings to the anticipated future growth rate of the company. A company with a PEG Ratio below one may be seen as undervalued while a PEG Ratio above one may signal that the company is overvalued. A PEG Ratio close to one may be considered to be fair value. Currently, the stock has a PEG Ratio of 13.510.

Let’s take a quick look at stock performance. Shares are currently trading $1.712 away from the 50-day moving average of $11.417 and $3.125 away from the 200-day moving average of $10.004. Shares are currently trading -8.445% away from the 52-week high price of 14.340 and +200.435% off the 52-week low of 4.370. Keeping an eye on the stock price relative to moving averages and yearly highs/lows may help evaluate future stock value.